Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes

Diabetic nephropathy (DN) is one of the most perilous side effects of diabetes mellitus type 1 and type 2 (T1DM and T2DM).). It is known that sodium/glucose cotransporter 2 inhibitors (SGLT 2i) and glucagone like peptide-1 receptor agonists (GLP-1 RAs) have renoprotective effects, but the molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Ninčević, Vjera, Omanović Kolarić, Tea, Roguljić, Hrvoje, Kizivat, Tomislav, Smolić, Martina, Bilić Ćurčić, Ines
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928920/
https://www.ncbi.nlm.nih.gov/pubmed/31757028
http://dx.doi.org/10.3390/ijms20235831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928920/
https://www.ncbi.nlm.nih.gov/pubmed/31757028
http://dx.doi.org/10.3390/ijms20235831

Ejemplares similares